{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:03:02Z","timestamp":1793520182840,"version":"4.5.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019717","name":"AstraZeneca Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004357","name":"Procter and Gamble","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019720","name":"GlaxoSmithKline Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020480","name":"CSL Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jaip.2022.03.002","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T13:33:47Z","timestamp":1647437627000},"page":"1434-1453.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":152,"title":["Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era"],"prefix":"10.1016","volume":"10","author":[{"given":"Joaquim","family":"Mullol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Buchheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.03.002_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2500\/ajra.2013.27.3981","article-title":"Epidemiology and differential diagnosis of nasal polyps","volume":"27","author":"Chaaban","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European Position Paper on Rhinosinusitis and Nasal Polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International Consensus Statement on Rhinology and Allergy: Rhinosinusitis","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.03.002_bib4","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaip.2018.10.014","article-title":"Clinical characteristics of patients with chronic rhinosinusitis without nasal polyps in an academic setting","volume":"7","author":"Benjamin","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.002_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2500\/ar.2015.6.0120","article-title":"Commentary on gender differences in prevalence, treatment, and quality of life of patients with chronic rhinosinusitis","volume":"6","author":"Ference","year":"2015","journal-title":"Allergy Rhinol (Providence)"},{"key":"10.1016\/j.jaip.2022.03.002_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/medicina55040095","article-title":"Inflammation and endotyping in chronic rhinosinusitis-a paradigm shift","volume":"55","author":"Ahern","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jaip.2022.03.002_bib7","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1398-9995.2008.01828.x","article-title":"Chronic rhinosinusitis and nasal polyps: the role of generic and specific questionnaires on assessing its impact on patient's quality of life","volume":"63","author":"Alobid","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib8","first-page":"61","article-title":"Article commentary: patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs)","volume":"6","author":"Weldring","year":"2013","journal-title":"Health Serv Insights"},{"key":"10.1016\/j.jaip.2022.03.002_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/coa.12189","article-title":"Quality of life and associated factors in persons with chronic rhinosinusitis in the general population: a prospective questionnaire and clinical cross-sectional study","volume":"38","author":"Lange","year":"2013","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jaip.2022.03.002_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4193\/Rhino16.211","article-title":"Symptoms of chronic rhinosinusitis differentially impact general health-related quality of life","volume":"54","author":"Hoehle","year":"2016","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/0003489415576181","article-title":"Altered quality of life and psychological health (SCL-90-R) in patients with chronic rhinosinusitis with nasal polyps","volume":"124","author":"Chung","year":"2015","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaip.2022.03.002_bib12","article-title":"Relationship of chronic rhinosinusitis with asthma, myocardial infarction, stroke, anxiety, and depression","volume":"8","author":"Kim","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.002_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/14787210.2017.1294063","article-title":"Sleep disruption in chronic rhinosinusitis","volume":"15","author":"Mahdavinia","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jaip.2022.03.002_bib14","doi-asserted-by":"crossref","first-page":"105947","DOI":"10.1016\/j.rmed.2020.105947","article-title":"Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: evidences from the Severe Asthma Network Italy (SANI) registry","volume":"166","author":"Canonica","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2022.03.002_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.rmed.2010.10.019","article-title":"The importance of smell in patients with bronchiectasis","volume":"105","author":"Guilemany","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2022.03.002_bib16","article-title":"Prevalence and clinical implications of chronic rhinosinusitis in people with bronchiectasis: a systematic review","volume":"7","author":"Handley","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.002_bib17","first-page":"343","article-title":"The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life","volume":"57","author":"Khan","year":"2019","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","article-title":"Chronic rhinosinusitis with nasal polyps and asthma","volume":"9","author":"Laidlaw","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.002_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/17476348.2021.1840983","article-title":"Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry","volume":"15","author":"Malipiero","year":"2021","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaip.2022.03.002_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2500\/aap.2020.41.200069","article-title":"Chronic rhinosinusitis with nasal polyps management in the age of biologics","volume":"41","author":"Blaiss","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2022.03.002_bib21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/lary.26391","article-title":"Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis","volume":"127","author":"DeConde","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2022.03.002_bib22","doi-asserted-by":"crossref","first-page":"100050","DOI":"10.1016\/j.waojou.2019.100050","article-title":"Biologics for the treatment of chronic rhinosinusitis with nasal polyps - state of the art","volume":"12","author":"Ren","year":"2019","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2022.03.002_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006680","article-title":"The burden of revision sinonasal surgery in the UK\u2014data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study","volume":"5","author":"Philpott","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaip.2022.03.002_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2213-2600(21)00457-4","article-title":"Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial","volume":"10","author":"Lourijsen","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2022.03.002_bib25","first-page":"CD013513","article-title":"Biologics for chronic rhinosinusitis","volume":"2","author":"Chong","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2022.03.002_bib26","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/all.13875","article-title":"EUFOREA consensus on biologics for CRSwNP with or without asthma","volume":"74","author":"Fokkens","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib27","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1080\/03007995.2020.1815682","article-title":"Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis","volume":"36","author":"Chen","year":"2020","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaip.2022.03.002_bib28","first-page":"CD011991","article-title":"Short-course oral steroids alone for chronic rhinosinusitis","volume":"4","author":"Head","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2022.03.002_bib29","first-page":"CD011994","article-title":"Systemic and topical antibiotics for chronic rhinosinusitis","volume":"4","author":"Head","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2022.03.002_bib30","first-page":"CD012453","article-title":"Topical and systemic antifungal therapy for chronic rhinosinusitis","volume":"9","author":"Head","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2022.03.002_bib31","first-page":"CD006991","article-title":"Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps","volume":"12","author":"Rimmer","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2022.03.002_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/all.14425","article-title":"EAACI Biologicals Guidelines-recommendations for severe asthma","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib33","first-page":"925","article-title":"Associations between the quality of life and nasal polyp size in patients suffering from chronic rhinosinusitis without nasal polyps, with nasal polyps or aspirin-exacerbated respiratory disease","volume":"9","author":"Schneider","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jaip.2022.03.002_bib34","first-page":"149","article-title":"A\u00a0study on the quality of life and mental health of sinusitis patients with olfactory disorders [in Chinese]","volume":"34","author":"Jia","year":"2020","journal-title":"Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"10.1016\/j.jaip.2022.03.002_bib35","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3109\/00016489.2010.539625","article-title":"Effects of smell loss on daily life and adopted coping strategies in patients with nasal polyposis with asthma","volume":"131","author":"Nordin","year":"2011","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.jaip.2022.03.002_bib36","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2020.01.024","article-title":"The sense of smell in chronic rhinosinusitis","volume":"145","author":"Mullol","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaip.2020.10.036","article-title":"The importance of considering olfactory dysfunction during the COVID-19 pandemic and in clinical practice","volume":"9","author":"Desai","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.002_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11882-020-00961-1","article-title":"The loss of smell and taste in the COVID-19 outbreak: a tale of many countries","volume":"20","author":"Mullol","year":"2020","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2022.03.002_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11882-020-00987-5","article-title":"Chemosensory dysfunction in patients with COVID-19: what do we learn from the global outbreak?","volume":"21","author":"Zeng","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2022.03.002_bib40","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/alr.22800","article-title":"Psychometric properties of the brief version of the questionnaire of olfactory disorders in patients with chronic rhinosinusitis","volume":"11","author":"Mattos","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.03.002_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/JAA.S290424","article-title":"Burden of disease in chronic rhinosinusitis with nasal polyps","volume":"14","author":"Bachert","year":"2021","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib42","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1007\/s00405-020-06575-7","article-title":"Impact of the smell loss on the quality of life and adopted coping strategies in COVID-19 patients","volume":"278","author":"Elkholi","year":"2021","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2022.03.002_bib43","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1002\/lary.24040","article-title":"Sleep quality and disease severity in patients with chronic rhinosinusitis","volume":"123","author":"Alt","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2022.03.002_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.sleep.2019.06.006","article-title":"Obstructive sleep apnea in patients with chronic rhinosinusitis with nasal polyps: a cross-sectional study","volume":"64","author":"Migueis","year":"2019","journal-title":"Sleep Med"},{"key":"10.1016\/j.jaip.2022.03.002_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4193\/Rhin16.065","article-title":"Sleep quality improves with endoscopic sinus surgery in patients with chronic rhinosinusitis and nasal polyposis","volume":"55","author":"V\u00e4rendh","year":"2017","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib46","first-page":"476","article-title":"Perioperative pain and anxiety in endoscopic sinus surgery [in German]","volume":"90","author":"Hosemann","year":"2011","journal-title":"Laryngorhinootologie"},{"key":"10.1016\/j.jaip.2022.03.002_bib47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4193\/RHINOL\/18.067","article-title":"Assessing quality of life and burden of disease in chronic rhinosinusitis: a review","volume":"2","author":"Klonaris","year":"2019","journal-title":"Rhinol Online"},{"key":"10.1016\/j.jaip.2022.03.002_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.10.012","article-title":"Patient-reported outcome measures for adult chronic rhinosinusitis: a systematic review and quality assessment","volume":"136","author":"Rudmik","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib49","first-page":"110","article-title":"Responsiveness and minimal clinically important difference for the EQ-5D in chronic rhinosinusitis","volume":"57","author":"Hoehle","year":"2019","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib50","first-page":"1","article-title":"A\u00a0concurrent validational study of the NCHS General Well-Being Schedule","volume":"73","author":"Fazio","year":"1977","journal-title":"Vital Health Stat 2"},{"key":"10.1016\/j.jaip.2022.03.002_bib51","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1023\/A:1008940902849","article-title":"Validity, reliability and acceptability of the Japanese version of the General Well-Being Schedule (GWBS)","volume":"9","author":"Nakayama","year":"2000","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jaip.2022.03.002_bib52","doi-asserted-by":"crossref","first-page":"a3006","DOI":"10.1136\/bmj.a3006","article-title":"Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review","volume":"338","author":"Contopoulos-Ioannidis","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2022.03.002_bib53","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/alr.22369","article-title":"Long-term outcomes of endoscopic sinus surgery in the management of adult chronic rhinosinusitis","volume":"9","author":"Smith","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.03.002_bib54","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jclinepi.2017.06.009","article-title":"Minimal important difference to infer changes in health-related quality of life-a systematic review","volume":"89","author":"Jayadevappa","year":"2017","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaip.2022.03.002_bib55","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/alr.21057","article-title":"Comparison of disease-specific quality-of-life instruments in the assessment of chronic rhinosinusitis","volume":"2","author":"Quintanilla-Dieck","year":"2012","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.03.002_bib56","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13601-018-0219-6","article-title":"Visual analogue scale for sino-nasal symptoms severity correlates with sino-nasal outcome test 22: paving the way for a simple outcome tool of CRS burden","volume":"8","author":"Doulaptsi","year":"2018","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib57","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1164\/ajrccm.158.4.9708130","article-title":"Is the Asthma Quality of Life Questionnaire a useful measure for low-income asthmatics?","volume":"58","author":"Leidy","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2022.03.002_bib58","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.otohns.2010.07.014","article-title":"Quality-of-life outcomes after endoscopic sinus surgery: how long is long enough?","volume":"143","author":"Soler","year":"2010","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2022.03.002_bib59","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/lary.25276","article-title":"Techniques for outcomes research in chronic sinusitis","volume":"125","author":"Gliklich","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2022.03.002_bib60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/fpsam.2019.29002.lin","article-title":"Improvement in snoring-related quality-of-life outcomes after functional nasal surgery","volume":"22","author":"Yamasaki","year":"2020","journal-title":"Facial Plast Surg Aesthet Med"},{"key":"10.1016\/j.jaip.2022.03.002_bib61","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s11136-004-6674-7","article-title":"Development and validation of a new health-related quality of life instrument for patients with sinusitis","volume":"14","author":"Atlas","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jaip.2022.03.002_bib62","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bjorl.2015.08.015","article-title":"The Portuguese version of the RhinoQOL Questionnaire: validation and clinical application","volume":"81","author":"Cerejeira","year":"2015","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2022.03.002_bib63","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0091-6749(99)70380-5","article-title":"Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire","volume":"104","author":"Juniper","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib64","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/all.12383","article-title":"Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper","volume":"69","author":"Pfaar","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib65","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1477-7525-3-68","article-title":"Evaluating change in health-related quality of life in adult rhinitis: responsiveness of the Rhinosinusitis Disability Index","volume":"3","author":"Chen","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jaip.2022.03.002_bib66","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4155\/cli.13.5","article-title":"Quality of life measures in patients on rhinosinusitis trials","volume":"3","author":"Lehrer","year":"2013","journal-title":"Clin Invest"},{"key":"10.1016\/j.jaip.2022.03.002_bib67","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2500\/105065895781808711","article-title":"Psychometric and clinimetric validity of the 31-item Rhinosinusitis Outcome Measure (RSOM-31)","volume":"9","author":"Piccirillo","year":"1995","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaip.2022.03.002_bib68","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item Sinonasal Outcome Test","volume":"34","author":"Hopkins","year":"2009","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jaip.2022.03.002_bib69","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/alr.22028","article-title":"Investigating the minimal clinically important difference for SNOT-22 symptom domains in surgically managed chronic rhinosinusitis","volume":"7","author":"Chowdhury","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.03.002_bib70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1067\/mhn.2002.121022","article-title":"Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20)","volume":"126","author":"Piccirillo","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2022.03.002_bib71","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2500\/ajra.2009.23.3259","article-title":"Validation of the Sino-Nasal Outcome Test 20 (SNOT-20) domains in nonsurgical patients","volume":"23","author":"Pynnonen","year":"2009","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib72","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/000348941112000304","article-title":"Revision rates after endoscopic sinus surgery: a recurrence analysis","volume":"120","author":"Mendelsohn","year":"2011","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaip.2022.03.002_bib73","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/1945892418770260","article-title":"Long-term clinical outcomes of aspirin desensitization with continuous daily aspirin therapy in aspirin-exacerbated respiratory disease","volume":"32","author":"Walters","year":"2018","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib74","article-title":"Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5R\u03b1 in a real-world setting","volume":"9","author":"Bavaro","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.002_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib76","article-title":"Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease","volume":"5","author":"Stevens","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.002_bib77","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jaip.2020.11.051","article-title":"Aspirin-exacerbated respiratory disease: association between patient-reported sinus and asthma morbidity","volume":"9","author":"Bergmark","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.002_bib78","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.jaip.2020.04.017","article-title":"A\u00a0retrospective analysis of bronchiectasis in patients with aspirin-exacerbated respiratory disease","volume":"8","author":"Chen","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.002_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2021.01.012","article-title":"Dupilumab improves upper- and lower-airway disease control in chronic rhinosinusitis with nasal polyps and asthma","volume":"126","author":"Laidlaw","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib80","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/all.13984","article-title":"Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis","volume":"75","author":"Bachert","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib81","doi-asserted-by":"crossref","first-page":"E1770","DOI":"10.1002\/lary.29230","article-title":"The effect of dupilumab on intractable chronic rhinosinusitis with nasal polyps in Japan","volume":"131","author":"Fujieda","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2022.03.002_bib82","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.03.002_bib83","article-title":"Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma","volume":"7","author":"Bachert","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.002_bib84","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2022.03.002_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2021.07.045","article-title":"Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study","volume":"149","author":"Gevaert","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib86","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib87","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1177\/1945892420972326","article-title":"Effects of omalizumab treatment in patients with recalcitrant nasal polyposis and mild asthma: a multicenter retrospective study","volume":"35","author":"Armengot-Carceller","year":"2021","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib88","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00405-019-05650-y","article-title":"Omalizumab versus intranasal steroids in the post-operative management of patients with allergic fungal rhinosinusitis","volume":"277","author":"Mostafa","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2022.03.002_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib90","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2022.03.002_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial","volume":"140","author":"Bachert","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib92","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/cea.13852","article-title":"Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial","volume":"51","author":"Tversky","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib93","doi-asserted-by":"crossref","first-page":"101965","DOI":"10.1016\/j.pupt.2020.101965","article-title":"Rapid effect of benralizumab for severe asthma with chronic rhinosinusitis with nasal polyps","volume":"64","author":"Matsuno","year":"2020","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaip.2022.03.002_bib94","doi-asserted-by":"crossref","DOI":"10.1177\/2058738420950851","article-title":"Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma","volume":"34","author":"Lombardo","year":"2020","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jaip.2022.03.002_bib95","doi-asserted-by":"crossref","first-page":"470","DOI":"10.18176\/jiaci.0602","article-title":"Omalizumab as a therapeutic option for nasal polyposis in moderate-to-severe persistent allergic asthma: evidence from a prospective study in a real-world setting","volume":"30","author":"Ruiz-Hornillos","year":"2020","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib96","doi-asserted-by":"crossref","first-page":"49","DOI":"10.18176\/jiaci.0391","article-title":"Effectiveness of omalizumab in severe allergic asthma and nasal polyposis: a real-life study","volume":"30","author":"Tiotiu","year":"2020","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib97","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4193\/Rhin17.139","article-title":"Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study","volume":"56","author":"Bidder","year":"2018","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib98","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/alr.22774","article-title":"Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: a real-world study","volume":"11","author":"Bajpai","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.03.002_bib99","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaci.2020.11.013","article-title":"EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management","volume":"147","author":"Bachert","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib100","first-page":"610","article-title":"Azithromycin for chronic eosinophilic rhinosinusitis with nasal polyp: a placebo-controlled trial","volume":"58","author":"de Oliveira","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib101","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bjorl.2015.03.018","article-title":"Evaluation of the improvement of quality of life with azithromycin in the treatment of eosinophilic nasal polyposis","volume":"82","author":"Oliveira","year":"2016","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2022.03.002_bib102","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.amjoto.2019.03.004","article-title":"The role of doxycycline in the management of chronic rhinosinusitis with nasal polyps","volume":"40","author":"Parasher","year":"2019","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.jaip.2022.03.002_bib103","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4193\/Rhino15.291","article-title":"Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps","volume":"55","author":"Pinto Bezerra Soter","year":"2017","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib104","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1398-9995.2011.02693.x","article-title":"Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial","volume":"66","author":"Videler","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib105","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/lary.26989","article-title":"Lack of long-term add-on effect by montelukast in postoperative chronic rhinosinusitis patients with nasal polyps","volume":"128","author":"Van Gerven","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2022.03.002_bib106","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/alr.22573","article-title":"Exhalation delivery system with fluticasone improves quality of life and health status: pooled analysis of phase 3 trials NAVIGATE I and II","volume":"10","author":"Soler","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.03.002_bib107","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1111\/all.14408","article-title":"Real-life assessment of chronic rhinosinusitis patients using mobile technology: the mySinusitisCoach project by EUFOREA","volume":"75","author":"Seys","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib108","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cea.12472","article-title":"Pathogenesis of nasal polyposis","volume":"45","author":"Hulse","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib109","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11882-020-00932-6","article-title":"Effect of functional endoscopic sinus surgery on outcomes in chronic rhinosinusitis","volume":"20","author":"Alanin","year":"2020","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2022.03.002_bib110","first-page":"305","article-title":"Impact of chronic rhinosinusitis therapy on quality of life: a prospective randomized controlled trial","volume":"48","author":"Ragab","year":"2010","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib111","first-page":"126","article-title":"Long-term outcomes of different endoscopic sinus surgery in recurrent chronic rhinosinusitis with nasal polyps and asthma","volume":"58","author":"Zhang","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib112","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib114","article-title":"Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD","volume":"7","author":"Laidlaw","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.002_bib118","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.anai.2020.08.066","article-title":"D202 Continued safety\/efficacy of omalizumab in chronic rhinosinusitis with nasal polyps: an open-label extension study","volume":"125","author":"Gevaert","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib119","doi-asserted-by":"crossref","first-page":"AB244","DOI":"10.1016\/j.jaci.2020.12.035","article-title":"The impact of omalizumab therapy on sleep in patients with nasal polyps","volume":"147","author":"Meltzer","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib121","doi-asserted-by":"crossref","first-page":"AB126","DOI":"10.1016\/j.jaci.2020.12.462","article-title":"Mepolizumab reduces disease symptoms for patients with chronic rhinosinusitis with nasal polyps: data from the SYNAPSE study","volume":"147","author":"Tabberer","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib122","article-title":"Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps","volume":"9","author":"Peters","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.03.002_bib123","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000519228","article-title":"Which is the best biologic for nasal polyps: dupilumab, omalizumab, or mepolizumab? A network meta-analysis","volume":"183","author":"Wu","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2021.08.030","article-title":"Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial","volume":"149","author":"Bachert","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.06.010","article-title":"NAVIGATE II: randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis","volume":"143","author":"Leopold","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.03.002_bib127","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1945892418810281","article-title":"NAVIGATE I: randomized, placebo-controlled, double-blind trial of the exhalation delivery system with fluticasone for chronic rhinosinusitis with nasal polyps","volume":"33","author":"Sindwani","year":"2019","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2022.03.002_bib128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/alr.21688","article-title":"Comparison of intranasal fluticasone spray, budesonide atomizer, and budesonide respules in patients with chronic rhinosinusitis with polyposis after endoscopic sinus surgery","volume":"6","author":"Neubauer","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.03.002_bib129","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3109\/00016489.2013.783715","article-title":"Effects of FESS and additional fluticasone propionate nasal drops on psychological well-being in nasal polyposis with asthma","volume":"133","author":"Nordin","year":"2013","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.jaip.2022.03.002_bib130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4193\/Rhin14.029","article-title":"Comparison between endonasal endoscopic polyp size scores and quality of life outcome after optimal medical treatment","volume":"52","author":"Aboud","year":"2014","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib131","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-154-5-201103010-00003","article-title":"Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial","volume":"154","author":"Vaidyanathan","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2022.03.002_bib132","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4193\/Rhino09.142","article-title":"Quality of life is improved by endoscopic surgery and fluticasone in nasal polyposis with asthma","volume":"48","author":"Olsson","year":"2010","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib133","first-page":"610","article-title":"Azithromycin for chronic eosinophilic rhinosinusitis with nasal polyp: a placebo-controlled trial","volume":"58","author":"de Oliveira","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib134","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.amjoto.2019.03.004","article-title":"The role of doxycycline in the management of chronic rhinosinusitis with nasal polyps","volume":"40","author":"Parasher","year":"2019","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.jaip.2022.03.002_bib135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4193\/Rhino15.291","article-title":"Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps","volume":"55","author":"Pinto Bezerra Soter","year":"2017","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib136","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bjorl.2015.03.018","article-title":"Evaluation of the improvement of quality of life with Azithromycin in the treatment of eosinophilic nasal polyposis","volume":"82","author":"Oliveira","year":"2016","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2022.03.002_bib137","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/jamaoto.2016.1249","article-title":"Effect of topical furosemide on rhinosinusal polyposis relapse after endoscopic sinus surgery: a randomized clinical trial","volume":"142","author":"Hashemian","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2022.03.002_bib138","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2213-2600(21)00457-4","article-title":"Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial","volume":"10","author":"Lourijsen","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2022.03.002_bib139","first-page":"126","article-title":"Long-term outcomes of different endoscopic sinus surgery in recurrent chronic rhinosinusitis with nasal polyps and asthma","volume":"58","author":"Zhang","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.03.002_bib140","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/alr.22369","article-title":"Long-term outcomes of endoscopic sinus surgery in the management of adult chronic rhinosinusitis","volume":"9","author":"Smith","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.03.002_bib141","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00405-015-3667-9","article-title":"Efficacy of ESS in chronic rhinosinusitis with and without nasal polyposis: a Danish cohort study","volume":"273","author":"Lind","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2022.03.002_bib142","first-page":"59","article-title":"Impact of endoscopic sinus surgery on the quality of life of patients with nasal polyposis","volume":"10","author":"Saedi","year":"2014","journal-title":"B-ENT"},{"key":"10.1016\/j.jaip.2022.03.002_bib143","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1177\/0194599811435638","article-title":"One year after endoscopic sinus surgery in polyposis: asthma, olfaction, and quality-of-life outcomes","volume":"146","author":"Ehnhage","year":"2012","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2022.03.002_bib144","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1017\/S0022215112001193","article-title":"Meticulous endoscopic sinus surgery to prevent recurrence of massive nasal polyposis","volume":"126","author":"Hoseini","year":"2012","journal-title":"J\u00a0Laryngol Otol"},{"key":"10.1016\/j.jaip.2022.03.002_bib145","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.otohns.2010.07.014","article-title":"Quality-of-life outcomes after endoscopic sinus surgery: how long is long enough?","volume":"143","author":"Soler","year":"2010","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2022.03.002_bib146","first-page":"305","article-title":"Impact of chronic rhinosinusitis therapy on quality of life: a prospective randomized controlled trial","volume":"48","author":"Ragab","year":"2010","journal-title":"Rhinology"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822002434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822002434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:33:37Z","timestamp":1761975217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822002434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":140,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2213219822002434"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.03.002","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}